Five years ago, Swiss multinational pharmaceutical company, Novartis, were facing a challenge. Customer service levels in its patented Innovative Medicines division had fallen and too many products were out of stock on a daily basis. In order to ensure availability of vital medicines to patients, the company decided to act. It embarked on a Class A programme with Oliver Wight to transform the supply side of the business. Find out what happened on their journey.
3M Automotive - Germany
Acraf Angelini - English version
ANSTO Asia Pacific
Australian Red Cross